Genentech: Breast cancer drug hits its mark in late-stage trial

A late-stage breast cancer trial showed that a Roche Group drug, combined with the popular cancer fighter Herceptin and chemotherapy, hit its main goal in women with a form of breast cancer that has spread to other parts of the body.